GlassScriptPhysician profile
Peter J Neidenbach
NPI 1316905631
$11,700.34
in general payments reported to CMS, 2019-2025
38 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,617 · 2020: $2,011 · 2021: $1,693 · 2022: $1,952 · 2023: $1,122 · 2024: $1,165 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,329 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,328.56 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,062.73 | 2019-2025 | |
| Janssen Biotech, INC. | $1,571.54 | 2019-2025 | Tremfya |
| Pfizer INC. | $1,041.90 | 2019-2025 | |
| Epi Health, LLC | $828.92 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $743.16 | 2019-2024 | Ilumya, Blu-U, Odomzo |
| Novartis Pharmaceuticals Corporation | $504.91 | 2019-2022 | |
| Leo Pharma INC. | $473.31 | 2020-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $467.10 | 2019-2025 | Ebglyss, Taltz |
| Galderma Laboratories, L.P. | $438.47 | 2019-2021 | |
| Genzyme Corporation | $357.12 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $356.64 | 2020-2022 | |
| Prugen, INC. Pharmaceuticals | $340.17 | 2020 | |
| Ucb, INC. | $301.87 | 2019-2025 | Bimzelx |
| Amgen INC. | $291.22 | 2020-2025 | Otezla, Otezla |
| Genentech USA, INC. | $282.85 | 2019-2024 | Erivedge |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Neidenbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.